Marvell Technology (NasdaqGS:MRVL) Q4 2026 Earnings call March 05, 2026 04:45 PM ET Speaker10Good afternoon, and welcome to Marvell Technology, Inc. fourth quarter and fiscal year 2026 earnings conference call. At this time, all participants are in listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. A question-and-answer session will follow the formal presentation. Please note that this event is being recorded. I will now tur ...

Omada Health (NasdaqGS:OMDA) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsAllan Kells - VP Investor of RelationsCraig Hettenbach - Managing DirectorDavid Roman - Managing DirectorElizabeth Anderson - Senior Managing DirectorRichard Close - Managing Director of Digital and Tech-Enabled Health Equity ResearchSean Duffy - Co-founder and CEOSteve Cook - CFOWei-Li Shao - PresidentConference Call ParticipantsCarly Becker - AnalystRyan MacDonald - Managing Director and Senior Equity Researc ...

Financial Data and Key Metrics Changes - In 2025, the company achieved record revenue growth for the 40th consecutive quarter, with adjusted EBITDA growing approximately 35% to a record $9.1 million, representing a margin of 22% [4][18] - Q4 2025 revenue reached $10.5 million, an 8% increase from Q4 2024, and a 10% annualized increase from Q3 2025 [12] - For the full year 2025, revenue grew 15% to $40.3 million from $35.2 million in 2024 [12] - Net loss in Q4 2025 was $1.1 million or $0.08 per share, an improvement from a net loss of $1.5 million or $0.12 per share in the same period last year [17] Business Line Data and Key Metrics Changes - The partner and marketplace channel grew 8% year-over-year in Q4 2025, representing approximately 59% of ARR, with full-year revenue increasing 10% to $22.2 million [12][13] - The enterprise channel grew 8% in Q4 2025 and 21% for the full year, reaching $18.1 million, driven by expansion into the EU [13] - Annual recurring revenue (ARR) at the end of Q4 2025 was $40 million, a 9% increase over the previous year [14] Market Data and Key Metrics Changes - The company is experiencing increased demand for digital accessibility solutions due to rising litigation and regulatory requirements, particularly in the EU [9][31] - The DOJ's requirements under Title II are set to go into effect next month, which is expected to drive further demand for the company's services [35] Company Strategy and Development Direction - The company is focusing on accelerating annual recurring revenue (ARR) growth while reducing reliance on non-recurring revenue [10][26] - A next-generation platform was released to address market needs, combining AI detection, expert audits, and custom fixes [7][8] - The company aims to leverage its proprietary data to enhance its product offerings and drive future growth [9][33] Management's Comments on Operating Environment and Future Outlook - Management anticipates that 2026 will see the highest year of digital accessibility lawsuits on record, indicating a growing market opportunity [7] - The company expects adjusted EBITDA to grow by at least 30% in 2026, with a run rate of $15 million by year-end [5][10] - Management expressed confidence in the company's unique position and the potential for significant growth driven by data and market dynamics [25][31] Other Important Information - The company repurchased approximately $4.6 million worth of shares in 2025, strengthening its balance sheet [18] - As of December 31, 2025, the company had $5.3 million in cash and $6.6 million in available debt facilities [19] Q&A Session Summary Question: Update on platform updates and human involvement in custom fixes - Management indicated that while AI tools are improving, significant human involvement is still necessary due to the complexity of accessibility issues [22] Question: Revenue guidance for 2026 and growth trends - Management provided conservative guidance for 2026, expecting lower non-recurring revenue and higher ARR growth [24][26] Question: Update on investments in the EU and opportunities - Management noted that the EU market is building nicely, with expectations for significant growth as enforcement of regulations increases [31] Question: Potential partnerships related to AI - Management highlighted the unique data the company possesses and the potential for future partnerships, though specific strategies were not disclosed [33] Question: Gross margin expectations for 2026 - Management expects gross margins to remain consistent, with opportunities for growth as AI compute costs are managed [36] Question: Customer additions and sustainability of growth - Management attributed recent customer additions to a large reseller deal in the EU and expressed optimism about continued momentum [41]

Financial Data and Key Metrics Changes - In Q4 2025, adjusted EBITDA increased by $2.2 million or 17.1% to $15.2 million compared to $13 million in Q4 2024 [4] - Q4 revenue was $90.9 million, a 4% decrease from the prior year period, but excluding flight equipment sales, revenue increased by 9.8% [4][5] - For the full year, total revenue was $335.3 million, a decrease of $9.8 million or 2.8% year-over-year, primarily due to fewer flight equipment sales [6] - Full year adjusted EBITDA increased by $12.8 million to $46.1 million, up 38.2% year-over-year [7] Business Line Data and Key Metrics Changes - Asset Management revenue in Q4 declined approximately 11.1% year-over-year to $56.9 million due to fewer flight equipment sales, but excluding these sales, revenue increased by 9.1% [14][15] - TechOps revenue in Q4 increased by 10.7% to $34 million, driven by higher sales in aerostructures and landing gear MROs [15] - For the full year, TechOps revenue declined by 4.5% to $123.7 million, primarily due to lower on-airport MRO activity, but gross margin improved to 25.6% from 16.6% in the prior year [16] Market Data and Key Metrics Changes - The company ended 2025 with a win rate of 4.8% in feedstock acquisitions, down from 17.2% in Q4 2024, indicating a hyper-competitive market [7][8] - The company has approximately $364 million in inventory at the start of 2026, with $150 million ready for deployment in the USM channel [28] Company Strategy and Development Direction - The company aims to mitigate earnings volatility by growing more recurring and predictable parts of the business, including expanding USM sales and increasing leasing activities [11] - Strategic adjustments in MRO facilities are expected to contribute significantly to profitability in 2026, with new capabilities and expanded capacity [10] - The company is committed to marketing its Enhanced Flight Vision System, AerAware, to both commercial and governmental customers [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving substantial growth in 2026, supported by efficiency initiatives and a strong balance sheet [12][19] - The company anticipates steady incremental improvements as new revenue streams ramp up and efficiency initiatives continue to gain traction [19] - Management noted that the GTF situation is not expected to normalize in 2026, which may impact operations [31] Other Important Information - The company received FAA approval to overhaul Boeing 737 MAX and 787 landing gear, expanding its capabilities [10] - The company is actively engaged in discussions with potential customers for its converted aircraft, with increased demand for cargo [9] Q&A Session Summary Question: What is the goal for material feedstock purchases this year? - Management anticipates a lower level of feedstock purchases this year due to a hyper-competitive market, with a win rate of under 10% [22][23] Question: How much inventory is available for monetization? - The company has ample inventory to continue growth without needing to purchase as much as last year, with $364 million in inventory at the start of 2026 [27][28] Question: How will GTF normalization and AerSafe deadline impact revenue? - Management does not expect GTF normalization in 2026, but sees opportunities in returning parked aircraft to service [31][41] Question: Will AerSafe create a headwind next year? - The greatest sales for AerSafe are expected this year, with a backlog exceeding last year's total sales [47]

Atea Pharmaceuticals (NasdaqGS:AVIR) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsAndrea Corcoran - CFO and EVP of LegalArantxa Horga - Chief Medical OfficerJanet Hammond - Chief Development OfficerJean-Pierre Sommadossi - CEO and FounderJohn Vavricka - Chief Commercial OfficerJonae Barnes - SVP of Investor Relations and Corporate CommunicationsJonathan Miller - Managing Director of Biotech and Pharma Equity ResearchConference Call ParticipantsAndy Hsieh - Biotech Research AnalystNon ...

Profound Medical (NasdaqCM:PROF) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsArun Menawat - Chairman and CEOChris Potter - Founder and CEOMathieu Burtnyk - COORashed Dewan - CFOStephen Kilmer - Director of Investor RelationsTom Tamberrino - CCOConference Call ParticipantsBen Haynor - Senior Research AnalystJohn McCauley - Equity Research AnalystMichael Freeman - Equity Research AnalystScott McAuley - Head of Research and Analyst, Healthcare and BiotechnologyOperatorGood day, and tha ...

OptimizeRx (NasdaqCM:OPRX) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsAndy D'Silva - Chief Business OfficerDavid Grossman - Managing DirectorEdward Stelmakh - Chief Financial and Strategic OfficerJeff Garro - Managing DirectorRyan Daniels - Group Head–Healthcare Technology and ServicesSteve Silvestro - CEOConference Call ParticipantsConstantine Davides - Managing Director and Senior Equity AnalystEric Martinuzzi - Senior Research AnalystOperatorGood afternoon, everyone, thank you f ...

Research Frontiers (NasdaqCM:REFR) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsArt Grady - InvestorJeff Harvey - InvestorJoe Harary - President and CEOJohn Nelson - InvestorMichael Forster - InvestorOperatorGood afternoon. Welcome to Research Frontiers investor conference call to discuss the fourth quarter and year-end 2025 results of operations and recent developments. The company will be answering many of the questions that were emailed to it prior to this conference call, either ...

Omada Health (NasdaqGS:OMDA) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsAllan Kells - VP Investor of RelationsCraig Hettenbach - Managing DirectorDavid Roman - Managing DirectorElizabeth Anderson - Senior Managing DirectorRichard Close - Managing Director of Digital and Tech-Enabled Health Equity ResearchSean Duffy - Co-founder and CEOSteve Cook - CFOWei-Li Shao - PresidentConference Call ParticipantsCarly Becker - AnalystRyan MacDonald - Managing Director and Senior Equity Researc ...

Gevo (NasdaqCM:GEVO) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsChris Ryan - President and COODerrick Whitfield - Managing DirectorDushyant Ailani - SVP of Equity ResearchEric Frey - VP of Finance and StrategyLeke Agiri - CFOPatrick Gruber - CEOPaul Bloom - PresidentPeter Gastreich - Managing Director of Energy Transition and Sustainable InvestingConference Call ParticipantsJeff Grampp - Managing Director and Senior Research AnalystSameer Joshi - Senior Equity Research AnalystOpera ...